First Eagle Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

First Eagle Investment Management’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-213,822	Closed	-$14.8M	–	179
2018 Q3	$14.8M	Sell	213,822 -12,511	-6%	-$948K	0.04%	120
2018 Q2	$17.1M	Sell	226,333 -274,589	-55%	-$17.3M	0.04%	117
2018 Q1	$26.4M	Sell	500,922 -100,583	-17%	-$5.85M	0.07%	106
2017 Q4	$32.1M	Hold	601,505	–	–	0.08%	111
2017 Q3	$35.9M	Sell	601,505 -50,000	-8%	-$3.02M	0.08%	128
2017 Q2	$51.4M	Sell	651,505 -9,500	-1%	-$777K	0.12%	105
2017 Q1	$54.8M	Buy	661,005 +26,200	+4%	+$1.95M	0.14%	99
2016 Q4	$50.4M	Buy	634,805 +66,600	+12%	+$4.84M	0.13%	111
2016 Q3	$39.8M	Buy	+568,205	New	+$31.5M	0.1%	128

Other funds holding EGRX

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

HEC

Hudson Executive Capital New York $50.9M AUM 22.11% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

First Eagle Investment Management's EGRX Position: Q4 2018 in Review

First Eagle Investment Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2018, closing a stake of 213,822 shares — an estimated $14.8M sold.

First Eagle Investment Management first reported a position in EGRX in Q3 2016 and held it in 9 quarters. The position peaked at $54.8M in Q1 2017. 182 funds tracked by Wall St. Rank hold EGRX as of Q4 2018.

First Eagle Investment Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
First Eagle Investment Management sold 213,822 Eagle Pharmaceuticals, Inc. shares in Q4 2018, an estimated $14.8M.
First Eagle Investment Management first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2016 and held it in 9 quarters.
First Eagle Investment Management's Eagle Pharmaceuticals, Inc. position peaked at $54.8M in Q1 2017.
182 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2018.

Based on First Eagle Investment Management's 13F filing for Q4 2018, filed 11 Feb 2019.